Updates are available Correction dated 2023-04-10

Article History

Received: 14 October 2022

Accepted: 18 January 2023

First Online: 7 February 2023

Change Date: 10 April 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s11739-023-03257-0

Declarations

:

: S.G. had honoraria for speaking at symposia from Pfizer and Daiichi-Sankyo and supports for attending meetings from Bayer, Daiichi-Sankyo and Pfizer; V.P. and L.C. had no conflict of interest to disclose; D.P had honoraria for educational events from Pfizer, Daiichi-Sankyo and Boehringer; A.S. had honoraria for lectures and/or participation on advisory board from Daiichi Sankyo, Bayer, Pfizer, Bristol-Myers Squibb, Sanofi, Werfen, Alexion, Roche, and Viatris.

: Not applicable.